BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,359,786 | -13.7% | 98,120 | +14.6% | 0.00% | 0.0% |
| Q2 2023 | $2,734,772 | +49.9% | 85,649 | +43.8% | 0.00% | 0.0% |
| Q1 2023 | $1,824,125 | +181.7% | 59,573 | +259.8% | 0.00% | – |
| Q4 2022 | $647,622 | -35.2% | 16,559 | -21.2% | 0.00% | – |
| Q3 2022 | $1,000,000 | -65.6% | 21,007 | -72.0% | 0.00% | -100.0% |
| Q2 2022 | $2,904,000 | -43.4% | 75,024 | -16.2% | 0.00% | 0.0% |
| Q1 2022 | $5,131,000 | -2.6% | 89,529 | +35.4% | 0.00% | 0.0% |
| Q4 2021 | $5,269,000 | +10.5% | 66,123 | +20.7% | 0.00% | 0.0% |
| Q3 2021 | $4,767,000 | -36.4% | 54,787 | -6.0% | 0.00% | -50.0% |
| Q2 2021 | $7,500,000 | +105.3% | 58,270 | +27.7% | 0.00% | +100.0% |
| Q1 2021 | $3,653,000 | +17.1% | 45,634 | +19.5% | 0.00% | 0.0% |
| Q4 2020 | $3,119,000 | +283.2% | 38,202 | +15.6% | 0.00% | – |
| Q3 2020 | $814,000 | +100.0% | 33,051 | +127.3% | 0.00% | – |
| Q2 2020 | $407,000 | +186.6% | 14,543 | +84.0% | 0.00% | – |
| Q1 2020 | $142,000 | – | 7,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |